Key result
CVD in women remains underrecognized and undertreated, frequently involving microvascular dysfunction and delayed care.
Why the study?
Cardiovascular disease is the leading cause of death in women but is often underrecognized and undertreated, with unique diagnostic and treatment challenges.
This review highlights the underrecognition and undertreatment of cardiovascular disease in women, emphasizing the role of nurses in advocacy and evidence-based primary prevention.
Answers are grounded in this paper and cite their sources.
Raises awareness of CVD undertreatment in women; leaves open impact of nurse-led advocacy on outcomes.
Cardiovascular disease (CVD) is the leading cause of death in women but is often underrecognized and undertreated. Women are more likely to experience delay in treatment and worse outcomes, even though they experience similar symptoms as men. Women are more likely to experience ischemia related to microvascular dysfunction, which is not readily diagnosed by commonly used diagnostic tests. Nurses are ideally positioned to be patient advocates and use evidence-based guidelines to encourage primary prevention and ensure prompt treatment. This paper provides an update on CVD in women for clinical nurses based on the latest research evidence.
No takes yet. Share an insight, caveat, or question.
Blakeman et al. (2023) conducted a review in Cardiovascular disease. Cardiovascular disease in women is often underrecognized and undertreated, with women more likely to experience ischemia related to microvascular dysfunction and delays in treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: